Objectives To determine the diversity of pulsed-field gel electrophoresis (PFGE) types among epidemic strains of methicillin-resistant Staphylococcus aureus (MRSA) recovered in Belgium, France, Germany and The Netherlands over the period 1981-94.
INTRODUCTION
In the past decade, methicillin-resistant Staphylococcus aureus (MRSA) strains have become major nosocomial pathogens [1] worldwide. In Europe, the prevalence of MRSA varies widely between countries and is consistently higher in southern countries like Italy, Spain and France, which report more than 30% as compared with less than 2% in northern parts such as Scandinavia, The Netherlands and Switzerland [2] . In Belgium, a national survey of bloodstream isolates conducted in 1989-91 in 144 Belgian acute-care hospitals showed a mean MRSA prevalence of 14% (range 0-70%) [3] . A more recent survey of S. aureus bacteremia conducted in 83 hospitals in 1995 showed that MRSA accounts for 21% of isolates [4] . Multiple studies have shown clonal spread of epidemic MRSA strains within hospitals [5, 6] , between hospitals within a country [7, 8] and also between countries [9, 10] . These events have been linked to interhospital transfer of either colonized patients or healthcare workers.
Epidemiologic typing of MRSA can be achieved by a number of molecular methods [5] [6] [7] [8] [9] [10] [11] [12] . Pulsed-field gel electrophoresis (PFGE) of genomic macrorestriction fragments has been recommended as a standard [13] . The advantages of PFGE include full typability, good reproducibility within centers, recognizable stability of genomic pattern relatedness over years and high discriminatory power. The usefulness of PFGE in monitoring the spread of epidemic MRSA strains at national or international level is well documented [5, 7, 10] .
The first objective of our study was to determine the geographic spread and diversity of PFGE types of epidemic Belgian MRSA from a national surveillance survey conducted in 1991-92. The second goal was to compare the relatedness of PFGE types of epidemic MRSA strains collected by reference centers in three European neighboring countries during 1981-94.
MATERIALS AND METHODS

Bacterial strains
Belgian survey During a Belgian survey conducted by the Groupement pour le Depistage et la Prévention des Infections Hospitalières (GDE-PIH-GOSPIZ) in 1991-92, up to 10 non-duplicate, consecutive MRSA isolates were collected from in-patients in 111 participating hospitals. Among these hospitals, 80 sent five or more MRSA strains representing a total of 681 isolates that were screened by phage typing. Three sets of MRSA strains were selected from this survey for molecular typing. A first set included a random sample of 72 isolates taken from each hospital with one or more locally epidemic phage type(s), defined as identical phage types recovered from −3 patients in a given hospital ( Table 1) . The second set of 57 strains originated from six hospitals during a local MRSA outbreak (i.e. a significant increase in local MRSA prevalence in 1989-91). The third set included 42 MRSA strains collected in five hospitals with an endemic MRSA setting (stable MRSA prevalence during 1989-91) [3] .
European survey
European MRSA strains (n = 102) were selected by national reference centers in Belgium, France, Germany and The Netherlands to include: (1) strains associated with epidemics in one or more hospitals; (2) strains collected during the period 1983-94; and (3) if any, MRSA strains with phage type 77 or 47/54/75/77/84/85, frequent epidemic phage types in Belgium during this period. This collection included strains from Belgium (n = 38, 1981-92), France (n = 24, 1985-94), Germany (n = 22, 1983-93) and The Netherlands (n = 18, 1985-94).
Antimicrobial susceptibility
MRSA isolates were confirmed by the oxacillin agar screen method and by multiplex PCR detection of mecA and nuc genes [14] . Minimal inhibitory concentration (MIC) determination was performed by the agar dilution method following NCCLS recommendations [15] for 17 antimicrobials (oxacillin, amoxicillin-clavulanic acid, vancomycin, teicoplanin, erythromycin, clindamycin, ciprofloxacin, gentamicin, amikacin, netilmicin, minocycline, rifampin, chloramphenicol, co-trimoxazole, fuci-din, imipenem and mupirocin) on 587 MRSA isolates from the Belgian survey. For interpretation of results, NCCLS breakpoints were used, except for fusidic acid, for which the Comité de l'Antibiogramme-Société Française de Microbiologie (CA-SFM) breakpoints of 2-32 mg/mL were used, and for mupirocin, for which 2-512 mg/mL breakpoints were used, as recommended by the manufacturer. Strains presenting intermediate MIC values were considered resistant.
Phage typing
The international basic set of phages was used at routine test dilution (RTD) and at RTD × 100 for strains non-typable at RTD [6] . Phage types were considered to be identical if ¾ 1 phage difference was observed.
Macrorestriction analysis
Genomic DNA extraction and SmaI restriction were performed as described before [6] . DNA fragments were separated by PFGE in a CHEF-Mapper system (Bio-Rad Laboratories, Nazareth, Belgium), using pulsing parameters of 5-15 s for 10 h followed by 15-45 s for 15 h. The SmaI genomic digest of S. aureus NCTC 8325 was used as molecular size marker.
Analysis of PFGE patterns
The similarity of macrorestriction patterns was determined both by visual comparison and by computer matching. Patterns differing by more than three fragments were considered to be distinct clones, and those differing by 1-3 fragments subclonal variants or subclones [6] . Polaroid negatives were scanned using the ScanJet II P system (Hewlett Packard, Brussels, Belgium) into TIFF files which were imported in GelCompar version 4.0 (Applied Maths, Kortrijk, Belgium). Bands in the size range between 36 and 700 kb were analyzed by Dice similarity coefficient with a position tolerance set to 0.8%. A dendrogram of similarity was built using the unweighted pair-group method using arithmetic averages (UPGMA). Clonal group level was set at − 80% similarity according to previously published data [6] .
RESULTS
Belgian survey
Phage typing
Of the 681 MRSA isolates, 185 (27%) were non-typable at RTD by the international set of phages. Among 496 typable MRSA strains, 237 (48%) belonged to type '77', 138 (28%) beloned to type '47/54/75/77/84/85', and 121 (24%) were divided into 35 distinct phage types, none of which included more than 4% of strains. Locally frequent epidemic phage types were predominantly type '77', recovered in 34 (55%) hospitals, and type '47/54/75/77/84/85', found in 14 (23%) ( Table 1) .
Antimicrobial susceptibility
The majority of MRSA strains analyzed were resistant to amoxicillin-clavulanic acid (96%), erythromycin (87%), clindamycin (82%), ciprofloxacin (94%) and gentamicin (90%). Among these strains, 57% were resistant to netilmicin, and only 15% and 9% were resistant to rifampin and co-trimoxazole, respectively. No strain was resistant to fusidic acid, mupirocin, vancomycin or teicoplanin. The resistance phenotype of locally epidemic MRSA strains is shown in 
PFGE typing
SmaI macrorestriction analysis of 72 MRSA strains presenting a locally epidemic phage type showed 24 patterns, which clustered into nine major types (Table 1) . Computer analysis showed three predominant groups of strains which clustered into closely related (× 80%) patterns (PFGE types 1, 2 and 3). The similarity between major PFGE types ranged from 36% to 72%. Three regionally epidemic types (types 1, 2 and 3) were found in − 2 hospitals. These epidemic types 1, 2 and 3 each represented 82%, 6% and 4% of all strains, respectively. Type 1 strains were subdivided into 13 subtypes by minor variations (1-3 bands) in the PFGE fragment patterns. The predominant subtypes 1a and 1b represented, respectively, 47% and 25% of type 1 strains.
The geographic distribution of type 1 strains showed dissemination to 54 (87%) Belgian hospitals located in eight of the nine provinces. They were present in 12 of 13 hospitals in Brussels. Type 2 strains were found in four (6%) hospitals located in Brussels and West-Flanders. Type 3 strains were found in three distant hospitals. Six types were found in a single hospital from the northern part of Belgium.
Concordance between PFGE analysis and phenotypic methods
The agreement between phage type and major PFGE types was low (57%). A better concordance was found for phage type 77-PFGE 1a (86% agreement) and phage type 47/54/75/77/84/85-PFGE 1b (80% agreement) ( Table 1) . These subtypes were distinguished by a shift of mobility of a single SmaI chromosomal DNA fragment from 324 kb to 262 kb.
Resistance patterns showed a concordance of 87% with PFGE types, with an excellent correlation between major PFGE type 1 and antibiotype 1 (94%) and between type 2 and antibiotype 2 (100%). Type 1 was resistant to 11 antibiotics (oxacillin, amoxycillin-clavulanic acid, rifampin, gentamicin, amikacin, netilmicin, ciprofloxacin, erythromycin, clindamycin, imipenem and co-trimoxazole). In contrast, type 2 strains were consistently susceptible to rifampin, gentamicin, amikacin, clindamycin, netilmicin and imipenem.
Correlation between PFGE type distribution and local MRSA prevalence Type 1 strains were more frequently represented in six hospitals in an epidemic setting as compared with five hospitals in an endemic setting, 80% versus 60% of strains (P = 0.005, Chisquare test). In these endemic hospitals, 14 sporadic PFGE types were found (each in a single patient), while in the epidemic hospitals, eight sporadic types were found, indicating a greater diversity of types in endemic hospitals.
European survey
PFGE analysis
MRSA isolates showed 78 SmaI patterns that clustered above 80% similarity into 32 major PFGE types by computer analysis (Figure 1) . By visual inspection, the same classification was obtained based on maximum three-fragment differences, except for 10 strains, which showed 2-4 fragment differences and 78-80% Dice coefficient of similarity with type 1 (type 1-related strains in Figure 1 ).
Five groups of closely (×80% similarity) related PFGE types appeared to be internationally disseminated (Figure 1) . The most widespread group was type 1, regrouping 42 strains from several regions of the four countries (Figure 1 ). Type 1 strains were isolated during the entire study period . Each of the four other internationally epidemic types was present in two or three countries: type 8 was found in Belgium and France, type 11 in France and The Netherlands, type 12 in Germany and The Netherlands, and type 10 in Belgium, France and Germany (Figures 1 and 2) . Outbreaks due to epidemic PFGE types 1 and 11 occurred in Dutch hospitals after transfer from a French hospital of a patient carrying a strain of these types. In addition, eight regionally epidemic types were found in several hospitals within one country, as follows: Germany, types 14, 16 and 27; The Netherlands, types 20 and 28; and Belgium, types 2 and 18.
DISCUSSION
This survey of epidemiologically documented MRSA strains from four western-European countries provides evidence of international spread of five epidemic MRSA strains. Molecular epidemiologic studies have demonstrated the spread of dominant MRSA clones in a number of European countries, including the UK [2, 9] , France [8, 12] , Spain and Portugal [5] , Germany [10] , Hungary [7] and Italy [9] . In our study, the most frequently represented clonal group of MRSA, described here as type 1 strains, was highly multiresistant. It was present in France and Belgium in the 1980s and was found to be associated with epidemics in The Netherlands and Germany in the 1990s. Local epidemics in The Netherlands were related to patient transfers from hospitals in France and Turkey. This clonal group 1 presented a considerable diversity of subclonal PFGE types in both European and Belgian isolates, which may be related to its relatively 'long' evolutionary history (on a microevolution scale) associated with its successful adaptation to a large human population reservoir in many different hospital ecosystems. Type 1 strains were closely similar by all markers used in our laboratory to type strains of the Iberian clone described by de Lencastre and colleagues [5] . Four other epidemic MRSA types appeared to be internationally disseminated in the 1990s but showed less extensive geographic ranges.
The comprehensive survey of MRSA strains from Belgian hospitals was conducted in the early 1990s, at a time when multiple local outbreaks were reported and the frequency of MRSA was rapidly increasing in many centers [3] . It revealed nine major PFGE types, three of which appeared to be regionally epidemic. The frequency of epidemic types by hospital was statistically associated with a recently increasing prevalence of MRSA. The predominant epidemic type 1 strains were multiresistant to antimicrobials and showed two major phage types. They were recovered from most Belgian hospitals, located in all parts of the country and in both epidemic and endemic settings. Two other regionally epidemic types were present in fewer Belgian hospitals. One of them, type 2, included strains which were susceptible to gentamicin, amikacin, and clindamycin and exhibited a PFGE profile very distant from that of type 1. Additional studies indicated that type 2 strains lack the aacA-aphD gene encoding the bifunctional aminoglycoside-modifying enzyme, which was carried by type 1 strains [16] . In contrast, type 2 strains showed an even higher [17] . This extreme level of resistance to fluoroquinolones may have conferred a selective advantage to these strains for transmission in hospital settings characterized by massive use of fluoroquinolones during that period.
Phage typing has long been used as a reference S. aureus typing method, but it is hampered by a substantial proportion of non-typable MRSA isolates and by variability of patterns, thereby leading to its replacement by PFGE typing in some reference laboratories [13] . For clonal delineation of S. aureus, PFGE analysis has emerged as one of the most discriminating methods. This method can detect some genomic modifications that arise from mutation in the recognition sites of the enzyme used and from recombination, deletion or insertion that affect the fragment size [6, 18] . During hospital outbreaks lasting for over a few years, subclonal PFGE variants of MRSA strains show size variation of one to three chromosomal fragments [6, 19] . Greater variation in pulsotypes was observed during subclonal evolution of endemic MRSA over three decades in one hospital [20] . In the present survey of MRSA strains associated with outbreaks in a large number of hospitals from European countries over more than a decade, PFGE analysis indicated substantial genotypic heterogeneity both at national and international levels. However, using a conservative definition of close relatedness between PFGE profiles (×80% similarity), a majority of these MRSA strains clustered into a limited number of closely related pulsotypes, suggesting that they belonged to the same clonal group and shared the same origin. The use of additional genotypic markers would be required to etablish the exact clonal relationships between these MRSA strains.
These data further document the widespread dissemination of several epidemic MRSA types across national borders of western continental Europe, presumably as a result of intra-and interhospital spread [7] [8] [9] [10] [11] . This hypothesis is corroborated by two lines of evidence. First, we found a significant statistical association between frequency of type 1 strains and local outbreaks in Belgian hospitals. Second, two MRSA outbreaks in The Netherlands were traced to an index patient carrying MRSA when repatriated from a hospital in a country where this PFGE type was endemic or epidemic.
These observations have a number of important implications. Firstly, they underscore the need to coordinate the strategies to control MRSA nosocomial transmission and prudent management when transferring colonized patients between institutions at regional and international levels [4] . Second, they stress the importance of improving national and international surveillance of MRSA infections. This could involve optimized genotyping methods and a uniform type nomenclature to track the evolution and diffusion of epidemic MRSA clones.
